Barinthus Biotherapeutics plcBRNS
那斯達克 · USD
0.73
+0.02
(+3.51%)
收盤 08/28 03:59 (UTC+8)
08/28 03:59 (UTC+8)
Barinthus Biotherapeutics plcBRNS
0.73
+0.02
(+3.51%)
財務數據
損益表
- -
- -
- 0.15
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | - | - | - | - | - | - | - | 14,969 | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | 14,969 | - | - |
營業費用 | 11,019 | 6,075 | 11,565 | 15,066 | 23,324 | - | - | - | - | - |
研發費用 | 3,923 | 3,593 | 3,931 | 5,390 | 7,953 | 8,290 | 8,310 | 11,139 | 11,662 | 11,125 |
推銷及管理費用 | 7,096 | 2,482 | 7,634 | 5,009 | 15,371 | 12,310 | 2,871 | 13,210 | 6,624 | 5,789 |
非經常性項目費用 | - | - | - | 4,667 | - | - | 12,209 | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -11,019 | -6,075 | -11,565 | -15,066 | -23,324 | -20,600 | -23,390 | -9,380 | -18,286 | -16,914 |
其他收入及費用 | 411 | 538 | 418 | 437 | 2,185 | 933 | 2,814 | 1,265 | 1,348 | 1,369 |
利息費用 | 14 | 13 | 13 | 13 | 12 | 13 | 12 | 17 | 12 | 12 |
稅前純益 | -10,622 | -5,550 | -11,160 | -14,642 | -21,151 | -19,680 | -20,588 | -8,132 | -16,950 | -15,557 |
所得稅 | -23 | -16 | -57 | -71 | -25 | -22 | 3 | -3 | -7 | -37 |
稅後純益 | -10,580 | -5,531 | -11,090 | -14,566 | -21,124 | -19,648 | -20,540 | -8,114 | -16,931 | -15,489 |
基本每股稅後盈餘(元) | -0.26 | -0.14 | - | -0.36 | -0.52 | -0.49 | - | -0.21 | -0.43 | -0.40 |
稀釋每股稅後盈餘(元) | -0.25 | -0.14 | -0.27 | -0.36 | -0.52 | -0.49 | -0.51 | -0.21 | -0.43 | -0.40 |
基本平均股數(千股) | 40848.00 | 40848.00 | - | 40661.00 | 40343.00 | 40265.00 | - | 39419.00 | 39041.00 | 38773.00 |
稀釋平均股數(千股) | 40848.00 | 40848.00 | - | 40661.00 | 40343.00 | 40265.00 | - | 39419.00 | 39041.00 | 38773.00 |
還原基本每股稅後盈餘(元) | -0.26 | -0.14 | - | -0.36 | -0.52 | -0.49 | - | -0.21 | -0.43 | -0.40 |
還原稀釋每股稅後盈餘(元) | -0.25 | -0.14 | -0.27 | -0.36 | -0.52 | -0.49 | -0.51 | -0.21 | -0.43 | -0.40 |
還原基本平均股數(千股) | 40,848 | 40,848 | - | 40,661 | 40,343 | 40,265 | - | 39,419 | 39,041 | 38,773 |
還原稀釋平均股數(千股) | 40,848 | 40,848 | - | 40,661 | 40,343 | 40,265 | - | 39,419 | 39,041 | 38,773 |
EBITDA(千元) | -9,769 | -4,678 | -10,225 | -13,723 | -19,136 | -17,623 | -19,097 | -6,625 | -15,459 | -14,084 |